The Bovine Tuberculosis Diagnosis Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Test Type (Serological Tests, Molecular Diagnostic Tests, Traditional Tests).
The Bovine Tuberculosis Diagnosis market in 2024 represents a critical component of veterinary public health efforts aimed at controlling and eradicating bovine tuberculosis (bTB), a zoonotic disease with significant economic and public health implications. Diagnostic tests, including tuberculin skin tests, interferon-gamma release assays (IGRAs), and molecular assays, enable accurate detection of Mycobacterium bovis infection in cattle herds, facilitating surveillance, quarantine measures, and disease management strategies. Market dynamics are influenced by regulatory mandates, trade restrictions, and research efforts aimed at improving diagnostic accuracy, specificity, and testing efficiency. Collaborative initiatives between veterinary authorities, diagnostic laboratories, and livestock producers aim to strengthen bTB control programs, mitigate transmission risks, and safeguard animal and human health, fostering global efforts towards bTB eradication and One Health objectives.
A prominent trend in the Bovine Tuberculosis Diagnosis market is the increasing focus on disease control measures in livestock populations. Bovine tuberculosis (bTB) poses significant economic and public health concerns due to its impact on animal productivity and zoonotic transmission risks. Governments, regulatory agencies, and livestock producers are implementing stringent surveillance and testing programs to control the spread of bTB. This trend is driving the demand for advanced diagnostic tools and technologies for accurate and timely detection of tuberculosis in cattle herds.
The primary driver for the Bovine Tuberculosis Diagnosis market is the implementation of regulatory mandates and growing public health concerns associated with bTB transmission. Regulatory bodies worldwide are enforcing mandatory testing and surveillance programs to monitor and control the prevalence of bTB in livestock populations. Additionally, heightened awareness of the zoonotic potential of bTB and its implications for human health have intensified efforts to improve disease detection and management in cattle. This regulatory pressure and public health awareness drive the adoption of diagnostic solutions for effective bTB control.
An opportunity in the Bovine Tuberculosis Diagnosis market lies in the development of rapid and portable diagnostic solutions for on-site testing in remote or resource-limited settings. Traditional diagnostic methods for bTB, such as tuberculin skin tests and culture-based assays, often require specialized laboratory facilities and trained personnel, leading to delays in diagnosis and challenges in surveillance efforts, especially in rural areas. By investing in the research and development of point-of-care diagnostics, companies can address the need for quick and accessible testing solutions, facilitating early detection and prompt management of bTB in cattle populations. This opportunity aligns with the increasing demand for convenient and cost-effective diagnostic tools to support effective disease control programs.
By Test Type
Serological Tests
Molecular Diagnostic Tests
Traditional Tests
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
AsureQuality Australia Pty Ltd
Bionote
Bio-Rad Laboratories Inc
Enfer Group
IDEXX Laboratories
IDvet
PBD Biotech Ltd
Thermo Fisher Scientific Inc
Zoetis
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Bovine Tuberculosis Diagnosis Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Bovine Tuberculosis Diagnosis Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Bovine Tuberculosis Diagnosis Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Bovine Tuberculosis Diagnosis Market Size Outlook, $ Million, 2021 to 2030
3.2 Bovine Tuberculosis Diagnosis Market Outlook by Type, $ Million, 2021 to 2030
3.3 Bovine Tuberculosis Diagnosis Market Outlook by Product, $ Million, 2021 to 2030
3.4 Bovine Tuberculosis Diagnosis Market Outlook by Application, $ Million, 2021 to 2030
3.5 Bovine Tuberculosis Diagnosis Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Bovine Tuberculosis Diagnosis Market Industry
4.2 Key Market Trends in Bovine Tuberculosis Diagnosis Market Industry
4.3 Potential Opportunities in Bovine Tuberculosis Diagnosis Market Industry
4.4 Key Challenges in Bovine Tuberculosis Diagnosis Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Bovine Tuberculosis Diagnosis Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Bovine Tuberculosis Diagnosis Market Outlook By Segments
7.1 Bovine Tuberculosis Diagnosis Market Outlook by Segments
By Test Type
Serological Tests
Molecular Diagnostic Tests
Traditional Tests
8 North America Bovine Tuberculosis Diagnosis Market Analysis And Outlook To 2030
8.1 Introduction to North America Bovine Tuberculosis Diagnosis Markets in 2024
8.2 North America Bovine Tuberculosis Diagnosis Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Bovine Tuberculosis Diagnosis Market size Outlook by Segments, 2021-2030
By Test Type
Serological Tests
Molecular Diagnostic Tests
Traditional Tests
9 Europe Bovine Tuberculosis Diagnosis Market Analysis And Outlook To 2030
9.1 Introduction to Europe Bovine Tuberculosis Diagnosis Markets in 2024
9.2 Europe Bovine Tuberculosis Diagnosis Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Bovine Tuberculosis Diagnosis Market Size Outlook By Segments, 2021-2030
By Test Type
Serological Tests
Molecular Diagnostic Tests
Traditional Tests
10 Asia Pacific Bovine Tuberculosis Diagnosis Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Bovine Tuberculosis Diagnosis Markets in 2024
10.2 Asia Pacific Bovine Tuberculosis Diagnosis Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Bovine Tuberculosis Diagnosis Market size Outlook by Segments, 2021-2030
By Test Type
Serological Tests
Molecular Diagnostic Tests
Traditional Tests
11 South America Bovine Tuberculosis Diagnosis Market Analysis And Outlook To 2030
11.1 Introduction to South America Bovine Tuberculosis Diagnosis Markets in 2024
11.2 South America Bovine Tuberculosis Diagnosis Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Bovine Tuberculosis Diagnosis Market size Outlook by Segments, 2021-2030
By Test Type
Serological Tests
Molecular Diagnostic Tests
Traditional Tests
12 Middle East And Africa Bovine Tuberculosis Diagnosis Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Bovine Tuberculosis Diagnosis Markets in 2024
12.2 Middle East and Africa Bovine Tuberculosis Diagnosis Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Bovine Tuberculosis Diagnosis Market size Outlook by Segments, 2021-2030
By Test Type
Serological Tests
Molecular Diagnostic Tests
Traditional Tests
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
AsureQuality Australia Pty Ltd
Bionote
Bio-Rad Laboratories Inc
Enfer Group
IDEXX Laboratories
IDvet
PBD Biotech Ltd
Thermo Fisher Scientific Inc
Zoetis
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Test Type
Serological Tests
Molecular Diagnostic Tests
Traditional Tests
The global Bovine Tuberculosis Diagnosis Market is one of the lucrative growth markets, poised to register a 4.9% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, AsureQuality Australia Pty Ltd, Bionote, Bio-Rad Laboratories Inc, Enfer Group, IDEXX Laboratories, IDvet, PBD Biotech Ltd, Thermo Fisher Scientific Inc, Zoetis
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume